Clinical Trial Update: Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial investigating optimal sequencing of pembrolizumab and platinum-based chemotherapy as first-line treatment for non-small cell lung cancer; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Alliance Foundation Trials, LLC. | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-12-28